What are the initiation rates and long-term adherence to secondary preventive drugs after acute myocardial infarction, and how do they differ by PCI status?
Non-PCI patients receive significantly fewer secondary preventive drugs after AMI compared to PCI patients, highlighting a critical gap in guideline-directed medical therapy.
Guideline-recommended secondary preventive drugs were prescribed to most patients discharged from hospital after AMI, but the percentage receiving such therapy was significantly lower in non-PCI patients. The long-time adherence was high, but few drug adjustments were performed during follow-up. More attention is needed to secondary preventive drug therapy in AMI patients not undergoing PCI.
Halvorsen et al. (Tue,) studied this question.